Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

The Katsina Command of the National Drugs Law Enforcement Agency (NDLEA), says it has arrested 734 suspects in connection with various drug-related offences in 2024. The Commander of NDLEA in the ...

Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Verseon, a pioneering company in physics- and AI-powered drug discovery, revealed that its AI technology significantly ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

A lawsuit filed by the Federal Trade Commission alleges Evoke Wellness LLC and its management services company used deceptive ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...